Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2020 3
2021 2
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
La terapia immunosoppressiva erogata ai pazienti dopo trapianto di cuore o polmone: lo studio Cesit.
Rosa AC, Finocchietti M, Bellini A, Oliveti A, Peritore D, Masiero L, Bedeschi G, Cardillo M, Lucenteforte E, Massari M, Spila Alegiani S, Leoni O, Mazzone A, Ferroni E, Pierobon S, Ledda S, Garau D, Addis A. Rosa AC, et al. Among authors: garau d. Recenti Prog Med. 2023 Sep;114(9):523-524. doi: 10.1701/4088.40795. Recenti Prog Med. 2023. PMID: 37530002 Italian. No abstract available.
An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT project.
Belleudi V, Rosa AC, Finocchietti M, Poggi FR, Marino ML, Massari M, Spila Alegiani S, Masiero L, Ricci A, Bedeschi G, Puoti F, Cardillo M, Pierobon S, Nordio M, Ferroni E, Zanforlini M, Piccolo G, Leone O, Ledda S, Carta P, Garau D, Lucenteforte E, Davoli M, Addis A; CESIT Study Group. Belleudi V, et al. Among authors: garau d. Front Pharmacol. 2022 Sep 15;13:959267. doi: 10.3389/fphar.2022.959267. eCollection 2022. Front Pharmacol. 2022. PMID: 36188626 Free PMC article.
Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project).
Rosa AC, Finocchietti M, Agabiti N, Menè P, Bracaccia ME, Bellini A, Massari M, Spila Alegiani S, Masiero L, Bedeschi G, Cardillo M, Lucenteforte E, Piccolo G, Leoni O, Ferroni E, Pierobon S, Nordio M, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT study group. Rosa AC, et al. Among authors: garau d. BMC Nephrol. 2023 Oct 27;24(1):320. doi: 10.1186/s12882-023-03325-9. BMC Nephrol. 2023. PMID: 37891504 Free PMC article.
Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project.
Franchi M, Vener C, Garau D, Kirchmayer U, Di Martino M, Romero M, De Carlo I, Scondotto S, Stival C, Della Porta MG, Passamonti F, Corrao G. Franchi M, et al. Among authors: garau d. Ther Adv Hematol. 2021 Feb 23;12:2040620721996488. doi: 10.1177/2040620721996488. eCollection 2021. Ther Adv Hematol. 2021. PMID: 33747423 Free PMC article.
Measuring multimorbidity inequality across Italy through the multisource comorbidity score: a nationwide study.
Corrao G, Rea F, Carle F, Di Martino M, De Palma R, Francesconi P, Lepore V, Merlino L, Scondotto S, Garau D, Spazzafumo L, Montagano G, Clagnan E, Martini N; working group “Monitoring and assessing care pathways (MAP)” of the Italian Ministry of Health. Corrao G, et al. Among authors: garau d. Eur J Public Health. 2020 Oct 1;30(5):916-921. doi: 10.1093/eurpub/ckaa063. Eur J Public Health. 2020. PMID: 32433750
Cardiovascular Risk After Adjuvant Trastuzumab in Early Breast Cancer: An Italian Population-Based Cohort Study.
Franchi M, Trama A, Merlo I, Minicozzi P, Tarantini L, Garau D, Kirchmayer U, Di Martino M, Romero M, De Carlo I, Scondotto S, Apolone G, Corrao G; FABIO working group. Franchi M, et al. Among authors: garau d. Oncologist. 2020 Oct;25(10):e1492-e1499. doi: 10.1634/theoncologist.2020-0216. Epub 2020 Aug 29. Oncologist. 2020. PMID: 32770690 Free PMC article.
Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study.
Finocchietti M, Marino ML, Rosa AC, Bellini A, Masiero L, Cardillo M, Massari M, Spila Alegiani S, Pierobon S, Ferroni E, Zanforlini M, Leoni O, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT Study Group. Finocchietti M, et al. Among authors: garau d. Drug Des Devel Ther. 2024 Jan 12;18:53-69. doi: 10.2147/DDDT.S431121. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38229916 Free PMC article.
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project.
Trifirò G, Isgrò V, Ingrasciotta Y, Ientile V, L'Abbate L, Foti SS, Belleudi V, Poggi F, Fontana A, Moretti U, Lora R, Sabaini A, Senesi I, Sorrentino C, Puzo MR, Padula A, Fusco M, Giordana R, Solfrini V, Puccini A, Rossi P, Del Zotto S, Leoni O, Zanforlini M, Ancona D, Bavaro V, Garau D, Ledda S, Scondotto S, Allotta A, Tuccori M, Gini R, Bucaneve G, Franchini D, Cavazzana A, Biasi V, Spila Alegiani S, Massari M; VALORE Project Collaborators. Trifirò G, et al. Among authors: garau d. BioDrugs. 2021 Nov;35(6):749-764. doi: 10.1007/s40259-021-00498-3. Epub 2021 Oct 12. BioDrugs. 2021. PMID: 34637126 Free PMC article.
Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study.
Bellini A, Finocchietti M, Rosa AC, Nordio M, Ferroni E, Massari M, Spila Alegiani S, Masiero L, Bedeschi G, Cardillo M, Lucenteforte E, Piccolo G, Leoni O, Pierobon S, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT study group. Bellini A, et al. Among authors: garau d. PLoS One. 2024 Jan 2;19(1):e0295205. doi: 10.1371/journal.pone.0295205. eCollection 2024. PLoS One. 2024. PMID: 38165971 Free PMC article.
11 results